As of Beijing time The data is from a third-party organization and is only for reference.
For actual information, please refer to：www.eastmoney.com
Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)
Tel: +1(626)986-9880
Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK
Tel: 0044 7790 816 954
Email: marketing@medicilon.com
Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)
Postcode: 201299
Tel: +86 (21) 5859-1500 (main line)
Fax: +86 (21) 5859-6369
© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3
Shanghai Public Network Security File No. 31011502018888 | Website Map
Business Inquiry
Global：
Email:marketing@medicilon.com
+1(626)986-9880(U.S.)
0044 7790 816 954 (Europe)
China：
Email: marketing@medicilon.com.cn
Tel: +86 (21) 5859-1500
In-depth and flexible application of organic chemistry knowledge and skills
The reasonable and efficient design of compound synthesis pathways
Protect the IP-related rights and interests of customers and ensure the authenticity and integrity of data.
Medicilon can undertake the synthesis of special reagents, intermediates and molecular fragments, preparation of standard products, synthesis design and preparation of impurities or metabolites, synthesis of stable isotope internal standards and synthesis of tritiated compounds.
Nine Development Trends of Chemical Synthetic Drugs
Six Directions of Chemical Synthesis Drug Research and Development
In-depth cross-direction of chemistry and biology for each program
Extensive use of advanced drug discovery technologies
Extensive experience in innovative designs and patent strategies
Responsive project management approach and effective communication
Rich knowledge reserve and project experience
Rapid follow-up and application of new technologies
Establishment of various popular target test models
Fast and reliable test data presentation
The company employs nearly 2,000 people.
Nearly 80% of employees have a bachelor's degree or above.
Master and Ph.D. accounted for nearly 25%
Share：
Relevant
news
marketing@medicilon.com
ABOUT
